These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12803833)

  • 21. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphonylureas and cancer: a case-control study.
    Monami M; Lamanna C; Balzi D; Marchionni N; Mannucci E
    Acta Diabetol; 2009 Dec; 46(4):279-84. PubMed ID: 19082520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes.
    Erdmann E
    Int J Cardiol; 2006 Feb; 107(2):147-53. PubMed ID: 15975669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
    Wascher TC; Boes U
    Clin Physiol Funct Imaging; 2005 Jan; 25(1):40-6. PubMed ID: 15659079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of gliclazide and left ventricular mass in type 2 diabetic patients.
    Pan NH; Lee TM; Lin MS; Huang CL; Chang NC
    Diabetes Res Clin Pract; 2006 Nov; 74(2):121-8. PubMed ID: 16631274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary n-acetyl-beta-d-glucosaminidase excretion: an indicator of neuropathy in type 2 diabetes.
    Kopf S; Oikonomou D; Zdunek D; von Eynatten M; Hess G; Nawroth PP; Bierhaus A; Humpert PM
    Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):601-6. PubMed ID: 24057510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
    Katakami N; Yamasaki Y; Hayaishi-Okano R; Ohtoshi K; Kaneto H; Matsuhisa M; Kosugi K; Hori M
    Diabetologia; 2004 Nov; 47(11):1906-13. PubMed ID: 15565373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin.
    Stefanović V; Antić S; Mitic-Zlatković M; Vlahović P
    Diabetes Metab Res Rev; 1999; 15(6):400-4. PubMed ID: 10634965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
    Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA
    Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of urinary excretion of N-acetyl-beta-glucosaminidase in diabetic retinopathy].
    Garbín Fuentes I ; Pérez Blanco FJ ; Pérez Chica G ; Moreno Terribas G ; Rodríguez Cuartero A ; Avilés Puigvert M
    Arch Soc Esp Oftalmol; 2000 Dec; 75(12):791-5. PubMed ID: 11151274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
    Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E; König E; Limmer J
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydrochloride pioglitazone decreases urinary cytokines excretion in type 2 diabetes.
    Hu YY; Ye SD; Zhao LL; Zheng M; Wu FZ; Chen Y
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):739-43. PubMed ID: 20874769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.